It seeks to identify key findings on BDNF as a marker for assessing the effectiveness of physical exercise and activity in managing symptoms and examines the association between exercise-/PA-induced changes in BDNF and the alleviation of specific symptoms, such as fatigue, pain, sleep disturbances, and depression. This evidence concerns the gene BDNF and depressive symptom measurement.